Company Genesystem Co., Ltd.

Equities

A363250

KR7363250002

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Annual profits - Rate of surprise

Sector Diagnostic & Testing Substances

End-of-day quote Korea S.E. Other stock markets 03:30:00 17/05/2024 am IST			5-day change	1st Jan Change
6,190 ^KRW	-0.16%		-0.48%	-33.65%

28/03	Genesystem Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.	CI
28/03	Genesystem Co., Ltd. authorizes a Buyback Plan.	CI

GeneSystem Co Ltd is a Korea-based company principally engaged in the development and manufacture of molecular diagnostic solutions. The Company is engaged in the development, manufacture and sale of platform based on molecular diagnosis. The Company develops and manufactures products such as molecular diagnosis systems, biochips, test kits, and reaction reagents, among others. The Company develops in vitro diagnostic technology through immunodiagnosis technology and molecular diagnosis technology.

KRW in Million	2022	Weight	2023	Weight	Delta
KIT Type 44.5 %	2,437	66.7 %	399	44.5 %	-83.61%
Molecular Diagnostic Apparatus 32.8 %	787	21.6 %	294	32.8 %	-62.62%
Reagents and Products 13.3 %	238	6.5 %	119	13.3 %	-50.02%
Others 4.4 %	128	3.5 %	40	4.4 %	-68.86%
Biochip 3.7 %	63	1.7 %	34	3.7 %	-46.89%
Consolidated Adjustment 1.0 %	-	-	9	1.0 %	-
Other Product 0.3 %	-	-	3	0.3 %	-

KRW in Million	2022	Weight	2023	Weight	Delta
Asia 52.0 %	1,682	46.1 %	467	52.0 %	-72.26%
South Korea 27.3 %	693	19.0 %	245	27.3 %	-64.63%
Europe 20.5 %	1,229	33.6 %	184	20.5 %	-85.03%
America 0.1 %	-	-	1	0.1 %	-

Managers	Title	Age	Since
Yu-Jin Seo CEO	Chief Executive Officer	55	01/13/01
Won-Jae Lee CTO	Chief Tech/Sci/R&D Officer	-	-
Sa-Cheol Hong BRD	Director/Board Member	66	-
Seok-Hoon Kim AUD	Comptroller/Controller/Auditor	52	-

Members of the board	Title	Age	Since
Sa-Cheol Hong BRD	Director/Board Member	66	-
Yu-Jin Seo CEO	Chief Executive Officer	55	01/13/01
Young-Won Park BRD	Director/Board Member	54	01/17/01
Dae-Shik Kim BRD	Director/Board Member	66	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	6,984,888	5,070,909 ( 72.60 %)	0	72.60 %

Name	Equities	%	Valuation
Yu-Jin Seo 15.22 %	1,063,000	15.22 %	5 M ₩
Mirae Asset Global Investments Co., Ltd. 7.230 %	505,000	7.230 %	2 M ₩
National Pension Service of Korea 7.087 %	495,000	7.087 %	2 M ₩
Ho-sung Yu 2.105 %	147,000	2.105 %	653 050 ₩
Electronics & Telecommunications Research Institute 2.015 %	140,763	2.015 %	625 342 ₩
Young-Won Park 0.6228 %	43,500	0.6228 %	193 250 ₩
Sa-Cheol Hong 0.1503 %	10,500	0.1503 %	46 646 ₩
Won-Jae Lee 0.1145 %	8,000	0.1145 %	35 540 ₩
Hyun-sook Kang 0.000000 %	0	0.000000 %	- ₩

Genesystem Co., Ltd

1662 Yuseong-daero Yuseong-gu

34054, Daejeon

http://www.genesystem.co.kr

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
GENESYSTEM CO., LTD.	-33.65%	31.95M
BIOMÉRIEUX	-4.67%	12.32B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-5.19%	8.07B
DIASORIN S.P.A.	+9.45%	5.91B
LANTHEUS HOLDINGS, INC.	+28.50%	5.52B
AUTOBIO DIAGNOSTICS CO., LTD.	-8.09%	4.21B
ANDON HEALTH CO., LTD.	+13.49%	2.73B
VITROLIFE AB	-1.34%	2.43B
MYRIAD GENETICS, INC.	+32.24%	2.29B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-3.55%	1.89B

Diagnostic & Testing Substances